Peering Into 2025: Will Next Year Be AI’s Huge Breakthrough Year?
With a wave of innovation having moved things forward in 2024, the AI horizon in 2025 looks bright
Read More
An AI Assistant Can Interpret Those Lab Results for You
When Judith Miller had routine blood work done in July, she got a phone alert the same day that her lab results were posted online. So, when her doctor messaged her the next day that her overall tests were fine, Miller wrote back to ask about the elevated carbon dioxide and low anion gap listed…
Uno Health Unveils Tool to Help Americans Check Eligibility for Financial Benefits
The Uno Savings Guide is a free resource that helps people check their eligibility for financial benefit programs, like Medicaid, Medicare Savings Programs and SNAP. The post Uno Health Unveils Tool to Help Americans Check Eligibility for Financial Benefits appeared first on MedCity News.
Innovative Strategies to Enhance Financial Predictability for Self-Funded Employers
Too often, the very systems meant to provide flexibility and control are undermined by delayed reimbursements, fragmented data, and a lack of transparency across the ecosystem. Solving this isn’t about tweaking the status quo, it requires a full redesign. The post Innovative Strategies to Enhance Financial Predictability for Self-Funded Employers appeared first on MedCity News.
Healthcare Leadership Strategies to Prevent Workplace Violence
Workers deserve environments that protect their well-being, and patients deserve care from professionals who aren’t operating in fear. The post Healthcare Leadership Strategies to Prevent Workplace Violence appeared first on MedCity News.
‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer
Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability. The post ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood…
Harris Backs Slashing Medical Debt. Trump’s ‘Concepts’ Worry Advocates.
Patient and consumer advocates are looking to Kamala Harris to accelerate federal efforts to help people struggling with medical debt if she prevails in next month’s presidential election. And they see the vice president and Democratic nominee as the best hope for preserving Americans’ access to health insurance. Comprehensive coverage that limits patients’ out-of-pocket costs…
The Top-Rated Suppliers of Lu-177 for Cancer Research
[Sponsored] With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients. The post The Top-Rated Suppliers of Lu-177 for Cancer Research appeared first on MedCity News.
Would delinking PBM reimbursement from rebates save money?
According to a Health Affairs Scholar paper by Geoffrey Joyce out this month, the answer is ‘yes’. He writes: Most PBM contracts tie their compensation to a percentage of a drug’s list price, creating a financial incentive to favor high-cost, high-rebate drugs on plan formularies at the expense of lower-cost generics and biosimilars. Furthermore, the…
How Ambience Is Saving Clinicians from ‘the Perpetual Dread’ of Documentation Overload
Idaho-based health system St. Luke’s is rolling out Ambience Healthcare’s AI platform across its enterprise following a successful pilot. The AI-powered scribing tool decreased clinicians’ documentation time by 39%. The post How Ambience Is Saving Clinicians from ‘the Perpetual Dread’ of Documentation Overload appeared first on MedCity News.